4//SEC Filing
Wyrick Susan D. 4
Accession 0001562180-25-002274
CIK 0001770121other
Filed
Mar 9, 8:00 PM ET
Accepted
Mar 10, 8:13 PM ET
Size
13.9 KB
Accession
0001562180-25-002274
Insider Transaction Report
Form 4
Wyrick Susan D.
See Remarks
Transactions
- Exercise/Conversion
Common Stock
2025-03-07+3,250→ 158,231 total - Award
Stock Option (Right to Buy)
2025-03-06+187,500→ 187,500 totalExercise: $2.55Exp: 2035-03-05→ Common Stock (187,500 underlying) - Exercise/Conversion
Restricted Stock Units
2025-03-07−3,250→ 9,750 total→ Common Stock (3,250 underlying) - Tax Payment
Common Stock
2025-03-10$2.56/sh−836$2,140→ 157,395 total - Award
Restricted Stock Units
2025-03-06+41,667→ 41,667 total→ Common Stock (41,667 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Sana Biotechnology, Inc. ("Sana") common stock.
- [F2]The restricted stock units vest in four equal installments on each of March 6, 2026, 2027, 2028 and 2029, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
- [F3]The option vests and becomes exercisable as to 25% of the underlying shares on March 6, 2026 and in 36 equal monthly installments thereafter, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
- [F4]The award vested as to 25% of the restricted stock units on March 7, 2025 and the remaining restricted stock units will vest in three equal installments on each of March 7, 2026, 2027 and 2028, provided that the reporting person provides continuous service to Sana as an employee, consultant, director or officer of Sana through each such date.
Documents
Issuer
Sana Biotechnology, Inc.
CIK 0001770121
Entity typeother
Related Parties
1- filerCIK 0001568605
Filing Metadata
- Form type
- 4
- Filed
- Mar 9, 8:00 PM ET
- Accepted
- Mar 10, 8:13 PM ET
- Size
- 13.9 KB